`______________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`APOTEX INC. and APOTEX CORP.,
`Petitioners,
` v.
`NOVARTIS AG,
`Patent Owner.
`______________________
`Case IPR2017-00854
`U.S. Patent No. 9,187,405
`______________________
`
`MOTION FOR ADMISSION PRO HAC VICE OF
`ROBERT W. TRENCHARD
`
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`
`
`
`
`
`
`
`I.
`
`Statement of Precise Relief Requested
`Novartis AG (“Novartis”) hereby respectfully requests that the Patent Trial
`
`and Appeal Board (the “Board”) admit Robert W. Trenchard pro hac vice in this
`
`proceeding under 37 C.F.R. § 42.10(c). Good cause exists for the Board to grant
`
`Novartis’s motion. Further, Petitioners Apotex Inc. and Apotex Corp. (collectively,
`
`“Apotex”) and Novartis have met and conferred, and Apotex does not object to
`
`Novartis’s motion.
`
`II.
`
`Statement of Facts Showing Good Cause for the Board to Recognize
`Counsel Pro Hac Vice During the Proceeding
`Under 37 C.F.R. § 42.10(c), the Board may admit counsel pro hac vice for
`
`good cause, so long as lead counsel is a registered practitioner and subject to any
`
`other conditions the Board requires. Under Section 42.10(c), good cause includes
`
`when “counsel is an experienced litigating attorney and has an established
`
`familiarity with the subject matter at issue in the proceeding.”
`
`This application satisfies the requirements of Section 42.10(c):
`
`1.
`
`Lead counsel, Jane M. Love, Ph.D., the undersigned, is a registered
`
`practitioner.
`
`2. Mr. Trenchard is an experienced litigator and has an established
`
`familiarity with the subject matter at issue here, as shown in his accompanying
`
`April 14, 2017 Declaration. (Ex. 2001 (Trenchard Declaration).) That declaration
`
`
`
`2
`
`
`
`
`
`
`
`shows that Mr. Trenchard has been a litigator for 22 years. He is a member in good
`
`standing of the New York and New Jersey State Bars, and is also admitted in several
`
`federal courts. He is also familiar with the subject matter of this case, including U.S.
`
`Pat. No. 9,187,405 (the “’405 patent”), the patent’s prosecution history, the
`
`underlying technology, and the prior art cited by the petitioner in this matter. In
`
`addition, he represents Novartis in related litigation and has met with ’405 patent
`
`inventors and authors of art cited in the Petition. (Ex. 2001 ¶¶ 2-7.)
`
`3.
`
`In his declaration, Mr. Trenchard also attests to each of the listed items
`
`required by the Order Authorizing Motion for Pro Hac Vice Admission in Unified
`
`Patents Inc. v. Parallel Iron, LLC, IPR2013-00639, Paper 7. (See Ex. 2001.)
`
`III. Conclusion
`For the foregoing reasons, Novartis respectfully requests that the Board admit
`
`Robert W. Trenchard pro hac vice in this proceeding.
`
`Respectfully Submitted,
`/Jane M. Love, Ph.D./
`Jane M. Love, Ph.D., Reg. No. 42,812
`GIBSON, DUNN & CRUTCHER LLP
`200 Park Avenue
`New York, NY 10166
`Jlove@gibsondunn.com
`Tel.: 212-351-3922
`Dated: May 1, 2017
`
`
`
`3
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`Pursuant to 37 C.F.R. § 4.26, I hereby certify that on May 1, 2017, true and
`
`accurate copies of:
`
` Motion for Admission Pro Hac Vice of Robert W. Trenchard;
`
` Ex. 2001: Declaration of Robert W. Trenchard in Support of Motion for
`
`Admission Pro Hac Vice; and
`
` Ex. 2002: Order Admitting Robert W. Trenchard Pro Hac Vice, Torrent
`
`Pharm. Ltd. v. Novartis AG, IPR2014-00784 (Paper 8)
`
`were served via electronic mail, on the following counsel of record for Petitioner:
`
`Steven W. Parmelee: sparmelee@wsgr.com
`Michael T. Rosato: mrosato@wsgr.com
`Jad. A. Mills: jmills@wsgr.com
`
`Wilson Sonsini Goodrich & Rosati
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104
`Telephone: 206-883-2542
`
`/Jane M. Love, Ph.D./
`Jane M. Love, Ph.D.
`Reg. No. 42,812
`
`
`
`
`
`
`
`
`
`Dated: May 1, 2017
`
`
`
`
`
`